Oksana Nizheborsky, NP

Oksana Nizheborsky practices at Scripps Memorial Hospital Encinitas in Encinitas, California, part of Scripps Health.

Oksana Nizheborsky's NPI, 1417336827, was assigned on May 19, 2015. Oksana Nizheborsky holds California license 674186.

Oksana Nizheborsky's primary practice is Scripps Memorial Hospital Encinitas, at 354 Santa Fe Drive, Encinitas, CA 92024 in San Diego County. The practice phone is (760) 753-6501.

Oksana Nizheborsky's primary practice is Scripps Memorial Hospital Encinitas in Encinitas, California, part of Scripps Health. The medical group on file is In-Patient Medical Group. Dmand AI also links Oksana Nizheborsky to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Oksana Nizheborsky practices, 2 sites in all. Vendor and product names are available with a free account.

Gerontology is Oksana Nizheborsky's primary specialty in the NPI Registry, under taxonomy code 363LG0600X. Oksana Nizheborsky is licensed in California.

CMS data shows 487 Medicare services from Oksana Nizheborsky across 1 procedure code in 2024, for 205 Medicare patients. Medicare paid $39,499 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 205 Medicare patients who saw Oksana Nizheborsky in 2024. The largest group is 75 to 84, with 84 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Oksana Nizheborsky's median patient age at 79, with 51% women.

Oksana Nizheborsky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Oksana Nizheborsky from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $120.